Detalhe da pesquisa
1.
Third dose of COVID-19 mRNA vaccine closes the gap in immune response between naïve nursing home residents and healthy adults.
Vaccine
; 41(17): 2829-2836, 2023 04 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36997386
2.
Safety and immunogenicity of a reduced dose of the BNT162b2 mRNA COVID-19 vaccine (REDU-VAC): A single blind, randomized, non-inferiority trial.
PLOS Glob Public Health
; 2(12): e0001308, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36962838